DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
72 hedge funds and large institutions have $391M invested in Dicerna Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 16
98% less call options, than puts
Call options by funds: $20K | Put options by funds: $1.19M
Holders
72
Holding in Top 10
8
Calls
$20K
Puts
$1.19M
Top Buyers
| 1 | +$6.13M | |
| 2 | +$5.68M | |
| 3 | +$4.3M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$4.06M |
| 5 |
Millennium Management
New York
|
+$3.26M |
Top Sellers
| 1 | -$9.87M | |
| 2 | -$4.06M | |
| 3 | -$4.01M | |
| 4 |
Renaissance Technologies
New York
|
-$2.59M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.39M |